Strengthening Australian Infectious Disease Clinical Research with a focus on vulnerable populations
- Funded by National Health and Medical Research Council (NHMRC)
- Total publications:0 publications
Grant number: GA271310
Grant search
Key facts
Disease
COVID-19Start & end year
20232027Known Financial Commitments (USD)
$1,520,363.31Funder
National Health and Medical Research Council (NHMRC)Principal Investigator
N/A
Research Location
AustraliaLead Research Institution
University of New South WalesResearch Priority Alignment
N/A
Research Category
14
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Drug usersVulnerable populations unspecified
Occupations of Interest
Unspecified
Abstract
This research aims to study treatments for infectious diseases that affect particularly vulnerable communities including people who inject drugs and people living with HIV. It focuses on finding solutions that will aid progress towards elimination of hepatitis B and C, and towards managing the pandemics of HIV and COVID-19, through the establishment of high quality international collaborative clinical research.